Becton, Dickinson and Company (BD)

Company

Investment-firm

Last deal

$540M

Amount

Post-IPO Equity

Stage

02.08.2023

Date

4

all rounds

$579M

Total amount

General

About Company
BD is a global medical technology company that improves medical discovery, diagnostics, and care delivery.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Becton, Dickinson and Co.

founded date

01.01.1897

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

BD, also known as Becton, Dickinson and Co., is a leading global medical technology company. They focus on advancing the world of health by enhancing medical research, clinical laboratories, and patient and healthcare worker safety. Their innovations contribute to improving medical discovery, diagnostics, and the delivery of care.
Contacts